ARCHIVES

Two Trials Presented at ASCO Demonstrate Drop in Death Risk, Increased Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

The Cancer Letter To End Print Edition In January

November 20, 2009

FDA Selects 23 Survivors To Review Drug Applications.

June 15, 2001

In Brief: Kerman New President Of ACCC, David Johnson Names President Elect; Wyder Gets NY Award

March 20, 1981

Committee Approves NDA For Tamoxifen

January 21, 1977

Yates Identifies “Probable”, “Potential” Core Grant Applicants

January 16, 1987

Kennedy Agrees To Drop Dollar Limit In New Cancer Bill

January 11, 1980